ClinicalTrials.Veeva

Menu

This Study Has Been Designed to Support the Working Hypothesis That Emergency Surgery in a Colon Obstruction Neoplasm is Better Than Stent Bridge Due to Better Oncological Outcomes, Analyzing the Importance of ERAS Programs in Emergency Colon Obstruction Surgery. (EUCOBS)

U

University of Zaragoza

Status

Invitation-only

Conditions

Colon Obstruction

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study has been designed to support the working hypothesis that emergency surgery in a colon obstruction neoplasm is better than stent bridge due to better oncological outcomes. The primary objective is to analyse the importance of ERAS program implementation in emergency colon obstruction surgery

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • All adult patients (aged >18 years) with a diagnosis of Malignant obstruction colorectal cancer. Informed consent will be obtained from all subjects who will participate in the study voluntarily.
  • ASA I, II and III
  • No more than 5 days from symptoms onset.
  • Absence of proximal colon severe dilatation( no more than 8 centimeters), severe malnutrition.
  • No Inmunocompromised patients
  • Patients suffer from segmentary colectomy, with or without anastomosis with o witjhout lateral ileostomy
  • Patients suffer from Hartmann procedure.

Exclusion criteria:

  • Patient refusal.
  • Patients under 18 years of age.
  • ASA IV
  • Stent placement
  • ICU stay more than 2 days
  • Peritonitis
  • Out of protocol if patient would need total parenteral nutrition(NPT) during postoperative or Clavien-Dindo more or equal than II.

Trial design

100 participants in 2 patient groups

Urgent
Description:
Patients with urgent surgery
Elective
Description:
Patients with elective surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems